Skip to main content
Top
Literature
1.
go back to reference Tarshish P, Bernstein J, Tobin JN, Edelmann CM (1992) Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone—a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6:123–130PubMed Tarshish P, Bernstein J, Tobin JN, Edelmann CM (1992) Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone—a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6:123–130PubMed
2.
go back to reference McEnery P (1990) Membranoproliferative glomerulonephritis: the Cincinnati experience—cumulative renal survival from 1957 to 1989. J Pediatr 116:S109–S114PubMed McEnery P (1990) Membranoproliferative glomerulonephritis: the Cincinnati experience—cumulative renal survival from 1957 to 1989. J Pediatr 116:S109–S114PubMed
3.
go back to reference Russo D, Minutolo R, Pisani A, Esposito R (2001) Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 38:18–25PubMed Russo D, Minutolo R, Pisani A, Esposito R (2001) Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 38:18–25PubMed
4.
go back to reference Hilgers KF, Mann JFE (2002) ACE inhibitors versus AT1 receptor antagonists in patients with chronic renal disease. J Am Soc Nephrol 13:1100–1108PubMed Hilgers KF, Mann JFE (2002) ACE inhibitors versus AT1 receptor antagonists in patients with chronic renal disease. J Am Soc Nephrol 13:1100–1108PubMed
Metadata
Title
Remission of membranoproliferative nephritis with angiotensin converting enzyme inhibition and receptor blockade
Author
Lavjay Butani
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 11/2003
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-003-1296-9

Other articles of this Issue 11/2003

Pediatric Nephrology 11/2003 Go to the issue

Announcements

November 2003